Zucchetti M - Search Results

1

Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.

Ballerini A, Moro F, Nerini IF, Marzo CM, Di Clemente A, Ferrari M, D'Incalci M, Biondi A, Colombini A, Conter V, Porcu L, Cervo L, Rizzari C, Zucchetti M. Ballerini A, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 2017 Jun;79(6):1267-1271. doi: 10.1007/s00280-017-3307-8. Epub 2017 Apr 19. Cancer Chemother Pharmacol. 2017. PMID: 28424964

2

Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.

Damia G, Tagliabue G, Zucchetti M, Davoli E, Sessa C, Cavalli F, D'Incalci M. Damia G, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 1992;30(6):459-64. doi: 10.1007/BF00685597. Cancer Chemother Pharmacol. 1992. PMID: 1394802

3

Do anticancer agents reach the tumor target in the human brain?

Donelli MG, Zucchetti M, D'Incalci M. Donelli MG, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 1992;30(4):251-60. doi: 10.1007/BF00686291. Cancer Chemother Pharmacol. 1992. PMID: 1643692 Review.

4

Concentrations of VP16 and VM26 in human brain tumors.

Zucchetti M, Rossi C, Knerich R, Donelli MG, Butti G, Silvani V, Gaetani P, D'Incalci M. Zucchetti M, et al. Ann Oncol. 1991 Jan;2(1):63-6. doi: 10.1093/oxfordjournals.annonc.a057826. Ann Oncol. 1991. PMID: 2009235 Free article.

5

Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.

Montaldo PG, Figoli F, Zanette ML, Sorio R, Zucchetti M, Tirelli U, D'Incalci M. Montaldo PG, et al. Among authors: zucchetti m. Oncology. 1990;47(1):55-61. doi: 10.1159/000226785. Oncology. 1990. PMID: 2300386

6

Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients.

Zanette L, Zucchetti M, Freshi A, Erranti D, Tirelli U, D'Incalci M. Zanette L, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 1990;25(6):445-8. doi: 10.1007/BF00686057. Cancer Chemother Pharmacol. 1990. PMID: 2311174

7

A gas chromatographic mass spectrometric assay for the determination of aphidicolin in plasma of cancer patients.

Rotondo S, Zucchetti M, Sessa C, D'Incalci M, Benfenati E, Fanelli R. Rotondo S, et al. Among authors: zucchetti m. J Pharm Sci. 1989 May;78(5):399-401. doi: 10.1002/jps.2600780511. J Pharm Sci. 1989. PMID: 2501472

8

Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation.

Zucchetti M, Catapano CV, Filippeschi S, Erba E, D'Incalci M. Zucchetti M, et al. Biochem Pharmacol. 1989 Jul 1;38(13):2069-75. doi: 10.1016/0006-2952(89)90059-2. Biochem Pharmacol. 1989. PMID: 2660797

9

Identification of microsomal metabolites of spirogermanium.

Benfenati E, Zucchetti M, D'Incalci M. Benfenati E, et al. Among authors: zucchetti m. Anticancer Res. 1989 Mar-Apr;9(2):507-10. Anticancer Res. 1989. PMID: 2751274

10

Lack of effect of cisplatin on i.v. L-PAM plasma pharmacokinetics in ovarian cancer patients.

Zucchetti M, D'Incalci M, Willems Y, Cavalli F, Sessa C. Zucchetti M, et al. Cancer Chemother Pharmacol. 1988;22(1):87-9. doi: 10.1007/BF00254189. Cancer Chemother Pharmacol. 1988. PMID: 3396150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page